M&A Deal Summary

West Pharmaceutical Services Acquires The Tech Group

On April 29, 2005, West Pharmaceutical Services acquired medical products company The Tech Group for 140M USD

Acquisition Highlights
  • This is West Pharmaceutical Services’ 1st transaction in the Medical Products sector.
  • This is West Pharmaceutical Services’ largest (disclosed) transaction.
  • This is West Pharmaceutical Services’ 2nd transaction in the United States.
  • This is West Pharmaceutical Services’ 1st transaction in Arizona.

M&A Deal Summary

Date 2005-04-29
Target The Tech Group
Sector Medical Products
Buyer(s) West Pharmaceutical Services
Deal Type Add-on Acquisition
Deal Value 140M USD

Target

The Tech Group

Phoenix, Arizona, United States
The Tech Group manufactures plastic components and assemblies for the pharmaceutical, medical device, consumer products and personal care markets.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

West Pharmaceutical Services

Exton, Pennsylvania, United States

Category Company
Founded 1923
Sector Packaging
Employees9,200
Revenue 3.0B USD (2023)
DESCRIPTION

West Pharmaceutical Services designs and manufactures packaging, diagnostic and delivery systems that promote the efficiency, reliability and safety of healthcare products. West Pharmaceutical Services was founded in 1923 and is based in Exton, Pennsylvania.


DEAL STATS #
Overall 2 of 3
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 2 of 3
State (Arizona) 1 of 1
Country (United States) 2 of 2
Year (2005) 2 of 3
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-02-14 Monarch Analytical Laboratories

Maumee, Ohio, United States

Monarch provides some of the largest U.S. pharmaceutical and medical device companies with a variety of analytical testing services.

Buy $6M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-07-05 Medimop Medical Projects

Ra'anana, Israel

Medimop provides customers with technologies and systems to enhance the reconstitution, transfer and administration of pharmaceutical products in therapeutic areas including multiple sclerosis, rheumatoid arthritis, vaccines, hormones and blood derivatives for haemophilia. Medimop's products, such as MIXJECT(R), offer customers a range of solutions for drug products requiring additional handling at the point of use, the market entered directly by West through the licensing and development of its Clip'n'Ject(R) product, a proprietary, single use drug reconstitution system currently in commercial use on one drug product.

Buy $36M